PHARMACY NEWSPAPER | 12/21/2022 – 19:53
Jaime Jesús Pérez, president of the Spanish Vaccination Associationand Ángel Gil de Miguel, Professor of Preventive Medicine and Public Health at the King Juan Carlos Universitythey presented this Wednesday a report on awareness of vaccination against Covid-19in an act moderated by José Manuel Freire, president of the Health Sciences Section of the Ateneo de Madrid.
Through this document, the experts remind the importance of the fourth dose compared to the COVID-19 and warn of the danger of low vaccination rates reaching in the fall campaign, where only 53.2% of over-60s received a booster dose with an adapted vaccine against COVID-19. Data that contrast with those of the previous booster dose, where 92% of people over 60 had received that dose.
The specialists recall that there are currently more than 4,400 people hospitalized for COVID in our country, therefore they recommend greater precaution at the gates of some dates in which family relationships can lead to a significant increase in the incidence (something that has been produced in the States United , for example, after Thanksgiving and the one that took place in our country in the previous two Christmases).
Although the epidemiological situation has been stable in recent weeks, these experts ensure that “the way to increase our safety in the coming months is to adequately protect ourselves with the administration of a vaccine dose adapted against COVID-19 and with which more than 7.5 million people have already been vaccinated in Spain since September 2022, reaffirming the safety of the vaccines mRNA”.
On the other hand, they indicate that although “having received the first two doses of the vaccine is a differential factor against the disease, the time elapsed influences the effectiveness of the vaccine. According to data published from the USA, the effectiveness of the first booster dose against hospitalization decreases over time, exceeding 85% during the first four months and reaching 45% when more than 8 months have elapsed8 in people over the age of 65 years old. This figure, albeit with different figures, is corroborated in numerous international bibliographies, with a marked role in this decrease both in the elapsed time and in the presence of the Ómicron variant, with which we have seen a greater immune escape”.
Follow us on social networks
